The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGresham Regulatory News (GHT)

Share Price Information for Gresham (GHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.00
Bid: 162.00
Ask: 164.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.235%)
Open: 162.00
High: 163.00
Low: 162.00
Prev. Close: 163.00
GHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 May 2016 08:45

RNS Number : 3153Y
Gresham Computing PLC
16 May 2016
 

16 May 2016

Gresham Computing plc

Directors' Dealings

Gresham Computing plc (LSE:GHT, "Company" or "Gresham") received notification on 13 May 2016 from Kestrel Partners LLP ("Kestrel") that on 13 May 2016 it acquired, on behalf of its discretionary clients, 50,000 ordinary shares of 5p each ("Shares") in the Company at a price of £1.00 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr Royde is a partner of, and holds a beneficial interest in Kestrel. Mr Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Gresham.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 7,802,209 Shares in the Company.

Of the Shares purchased, 40,000 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr Royde is deemed to have a beneficial interest in) 7,007,664 Shares in the Company. The remaining 10,000 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Royde has no beneficial interest, who, following this transaction, hold a further 844,545 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 7,852,209 Shares in the Company, which represents approximately 12.41% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

7,007,664

11.08%

Indirect

JIM Nominees Limited

297,545

0.47%

Indirect

Bank of New York Nominees Ltd

547,000

0.86%

 

- Ends -

 

For further information, please contact:

Gresham Computing plc

Ian Manocha

Rob Grubb

Jonathan Cathie

+44 (0) 20 7653 0200

N+1 Singer (broker)Shaun Dobson

Lauren Kettle

+44 (0) 20 7496 3000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFMSWMFMSEEI
Date   Source Headline
18th May 20185:46 pmRNSHolding(s) in Company
17th May 20187:00 amRNSCapital Markets Day
10th May 20183:09 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Statement
9th May 20187:00 amRNSClareti Contract Win with Global Tier 1 Bank
26th Apr 20189:26 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSGresham win Queen's Award for Enterprise
19th Apr 20187:00 amRNSExercise of Options
17th Apr 20187:00 amRNSClareti Cloud Win
6th Apr 20187:00 amRNSExercise of Options
4th Apr 20187:00 amRNSNotice of Annual General Meeting
16th Mar 201810:34 amRNSHolding(s) in Company
15th Mar 201812:57 pmRNSGrant of Options
13th Mar 20187:00 amRNSFinal Results
27th Feb 20187:00 amRNSNotice of Results & Results Presentations
5th Feb 20187:00 amRNSDirectorate Change
15th Jan 20187:00 amRNSAppointment of Chief Marketing Officer
10th Jan 201811:57 amRNSHolding(s) in Company
9th Jan 20187:00 amRNSTrading Update
29th Dec 20179:52 amRNSSignificant CTC banking contract win in Europe
11th Dec 20174:12 pmRNSResult of General Meeting
22nd Nov 20177:00 amRNSProposed Share Bonus Plan and Notice of GM
4th Oct 20177:00 amRNSTrading Update
22nd Sep 201710:05 amRNSHolding(s) in Company
21st Sep 20172:32 pmRNSHolding(s) in Company
13th Sep 20177:00 amRNSExercise of Options
5th Sep 20177:00 amRNSDirectorate Change
30th Aug 20174:43 pmRNSHolding(s) in Company
29th Aug 20177:00 amRNSNorth American Tier 1 bank win for CTC
22nd Aug 20173:30 pmRNSHolding(s) in Company
27th Jul 20175:05 pmRNSHolding(s) in Company
25th Jul 20177:00 amRNSHalf-year Report
7th Jul 20177:00 amRNSAppointment of Joint Broker
5th Jul 20177:00 amRNSTrading Update
3rd Jul 20177:00 amRNSSignificant New Clareti Contract Win
13th Jun 20177:00 amRNSExercise of Options & TVR
9th May 20174:39 pmRNSHolding(s) in Company
4th May 201712:51 pmRNSResult of AGM
4th May 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSDirectorate Change
30th Mar 20179:11 amRNSReal-time analytics added to the Clareti platform
28th Mar 20173:57 pmRNSNotice of AGM
27th Mar 20177:00 amRNSIssue of Equity
14th Mar 20177:00 amRNSFinal Results
2nd Mar 20177:00 amRNSNotice of Results and Results Presentations
9th Jan 20177:00 amRNSTrading Update
6th Jan 201711:47 amRNSHolding(s) in Company
28th Dec 20169:23 amRNSFirst US Tier 1 Bank Contract Win for CTC
15th Dec 20167:00 amRNSContract Win for Clareti Transaction Control
9th Dec 20164:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.